Diu Nguyen

Queen Mary University of London — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index2.1kcitations25works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Research and Splicing(14), RNA modifications and cancer(11), Cancer-related gene regulation(9), RNA and protein synthesis mechanisms(4), Acute Myeloid Leukemia Research(3)

Publications25 total

Functional plasticity of RNA-binding proteins in cancer: both friend and foe
Trends in cancer·2025Open Access
Investigating ribosome biogenesis in AML identifies MYB-binding protein 1A (MYBBP1A) as an essential regulator of leukemia cells
Blood·2025Open Access
β-Catenin interacts with canonical RBPs including MSI2 to associate with a Wnt signalling mRNA network in myeloid leukaemia cells
Oncogene·2025· 5 citedOpen Access
β-Catenin interacts with a Wnt signaling mRNA network in myeloid leukaemia cells through canonical RBP binding.
2025Open Access
Rbmx Regulates YTHDC1 Nuclear Condensates to Promote Nascent Transcription in Acute Myeloid Leukemia
Blood·2024
Uncovering the HOXA9 Translational Regulatory Complex That Promotes AML Leukemic Stem Cells
Blood·2024
β-Catenin associates with a Wnt signaling mRNA network in myeloid cells through canonical RBP binding
2024· 3 citedOpen Access
RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoietic stem and progenitor cells
Nature Communications·2023· 20 citedOpen Access
<i>BTG1</i> mutation yields supercompetitive B cells primed for malignant transformation
Science·2023· 39 citedOpen Access
The 2022 generation
Nature Cancer·2022· 1 citedOpen Access
Abstract A24: <i>BTG1</i> mutations confer a fitness advantage and promote aggressive B cell lymphoma development by lowering the threshold for MYC induction
Blood Cancer Discovery·2022
<i>BTG1</i> Mutation Promotes Aggressive Lymphoma Development By Lowering the Threshold to MYC Activation and Generating "Super-Competitor" B Cells
Blood·2021· 2 cited
RNA Binding Protein Syncrip Is Required for the Low-Output HSC By Sustaining Proteome Quality
Blood·2021
2007 – TRANSCRIPTIONAL CONTROL OF CBX5 BY THE RNA BINDING PROTEINS RBMX AND RBMXL1 MAINTAINS CHROMATIN STATE IN MYELOID LEUKEMIA
Experimental Hematology·2021· 1 cited
Transcriptional control of CBX5 by the RNA-binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia
Nature Cancer·2021· 31 citedOpen Access
N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation
Cancer Cell·2021· 233 citedOpen Access
Transcriptional Control of HP1a By the RNA Binding Proteins Rbmx/L1 Maintain Chromatin State in Myeloid Leukemia
Blood·2020· 2 cited
HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells
Nature Communications·2020· 69 citedOpen Access
m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment
Cell Reports·2019· 163 citedOpen Access
The RNA Binding Protein MSI2 Has Increased RNA Binding Activity in Leukemic Stem Cells Compared to Normal Hematopoietic Stem Cells
Blood·2018· 1 cited
page 1 of 2Next →

Frequent Co-authors

Michael G. Kharas(18), Ly Vu(12), Ersilia Barin(10), Alexandra Schurer(9), Saroj Gourkanti(7), Christina S. Leslie(7), Timothy Chou(6), Samie R. Jaffrey(6), Hanzhi Luo(6), Camila Prieto(6), Yuanming Cheng(5), Arthur Chow(5), Ari Melnick(5), Brian F. Pickering(4), Angela Maria Savino(4), Xuejing Yang(4), Anthony Velleca(4), Thomas Rohwetter(4), Christopher R. Chin(4), Zhaoqi Liu(4)